6th Cannabinoid-Derived Drug Development Summit

With a brand-new agenda, the 6th Cannabinoid-Derived Drug Development Summit is the ideal platform for preclinical and clinical scientists, R and D leaders, and drug developers to keep up with the latest innovations in cannabinoid in vivo and in vitro translation, bioavailability, dosage and delivery, and choosing clinical trial outcomes.

Join forces with industry leaders like Jazz Pharmaceuticals, GB Sciences, Alterola, Avicanna and Roche as they collaborate to overcome DMPK, clinical placebo effect, and translational potency; and discuss novel translational and clinical data for neurology and pain, cardiometabolic, dermatology, oncology and more.

Meet with over 80 scientists to achieve FDA accepted and patient compliant dosage regimes for CBD therapeutics, and be part of intimate discussions only available, year on year, at this conference.

URLs:
Website: https://go.evvnt.com/1768333-0?pid=10018
Tickets: https://go.evvnt.com/1768333-2?pid=10018
Brochure: https://go.evvnt.com/1768333-3?pid=10018

Prices:
Drug Developers | Conference + Workshop: USD 3098.00,
Drug Developers | Conference Only: USD 2599.00,
Solution Providers | Conference + Workshop: USD 4548.00,
Solution Providers | Conference Only: USD 3799.00

Speakers: Dr. Pritesh Kumar | Director of Cannabinoid Research | Canadore College, Frantz Le Devedec | Executive Vice President - Research and Product Development | Avicanna Inc., Guillermo Moreno | Sanz Global Scientific Director | Khiron Life Sciences Corp., Guy Webber | Preclinical Development Director | Alterola Biotech Inc., Hunter Land | Vice President - Research and Development | Biopharmaceutical Research Co., Jackie Lee | Founder and Chief Scientific Officer | Auxilio Pharmaceuticals, James Mongiardo | President | Gefion Canada Inc., Jennifer Triemstra | Associate Director, Medical Affairs, Cannabinoid Education | Jazz Pharmaceuticals Inc, Jim Smeeding | President and Co Founder | Indication BioScience LLC, Karolina Urban | Vice President - Scientific and Medical Affairs Avicanna Inc., Kathryn Nichol | Co-Founder and Chief | LivaNova, Mark Kindy | Professor and Director | University of South Florida, Mark Rosenfeld | Founder and Chief Innovation Officer | Ananda Scientific, Tamas Biro | Principal Scientific Advisor | Alterola Biotech Inc., Tim Lefever | Director of Discovery | Nalu Bio, Uwe Grether | Expert Scientist and Project Leader Medicinal Chemistry | Roche